DNA-encoded Library Market To Reach $1.60 Billion By 2030

DNA-encoded Library Market Growth & Trends

The global DNA-encoded library market size is expected to reach USD 1.60 billion by 2030, growing at a CAGR of 13.4% from 2025 to 2030, according to a new report by Grand View Research, Inc. The rising demand for novel and targeted drug discovery is one of the key factors driving the market growth. These libraries enable high-throughput screening of vast chemical compounds, significantly accelerating the identification of potential drug candidates. Traditional methods for screening chemical compounds can be time-consuming and resource-intensive, but DNA-encoded libraries streamline this process by attaching a unique DNA sequence to each compound, making it possible to rapidly identify and evaluate numerous candidates simultaneously. This efficiency is a major advantage in drug discovery, where speed and accuracy are critical.

Another significant factor propelling the growth of the DNA-encoded library industry is the increasing focus on precision medicine. As the healthcare industry moves toward more personalized treatments, the ability to discover drugs that specifically target individual genetic profiles becomes more valuable. DNA-encoded libraries offer a unique solution by enabling the creation of highly diverse libraries that can be tailored to target specific disease pathways or patient populations. This is particularly beneficial in the fields of oncology and genetic disorders, where personalized therapies have shown great promise in improving treatment outcomes.

The rising prevalence of chronic diseases, such as cancer, autoimmune disorders, and infectious diseases, is also contributing to the market growth. The increasing burden of these diseases worldwide has spurred investments in drug discovery technologies that can lead to faster development of effective treatments. DNA-encoded libraries play a critical role in this by facilitating the discovery of novel small molecules, antibodies, and other biologics that can potentially address unmet medical needs. In particular, the growing interest in antibody-based therapies and immunotherapies has highlighted the importance of efficient drug discovery methods like DNA-encoded libraries.

Technological advancements in genomics and bioinformatics have further fueled the market's growth. As sequencing technologies have become more advanced and cost-effective, the ability to construct large, highly diverse DNA-encoded libraries has improved. The integration of bioinformatics tools has also enhanced the ability to analyze complex data, allowing researchers to optimize the selection of candidates and improve the efficiency of the drug discovery process. These advancements have made DNA-encoded libraries more accessible and effective, driving their adoption across pharmaceutical and biotechnology companies.

In addition, the increasing number of collaborations and partnerships between pharmaceutical companies, academic institutions, and contract research organizations is driving market expansion. These collaborations enable the sharing of resources and expertise, accelerating the development and application of DNA-encoded library technology in drug discovery. The market is also supported by increasing funding from both public and private sectors, as the potential for breakthrough drugs remains high. Together, these factors are creating a conducive environment for the growth and expansion of the DNA-encoded library market.

 Request a free sample copy or view report summary: DNA-encoded Library Market Report

DNA-encoded Library Market Report Highlights

• The services segment led the DNA-encoded library industry, generating the highest revenue in 2024, driven by the increasing outsourcing of drug discovery research.

• Based on therapeutic area, the oncology segment held the largest revenue share of 38.32% in 2024, primarily due to the high demand for targeted cancer therapies.

• Based on application, the hit generation/identification segment dominated the market in 2024 with a share of 42.52%, due to the growing need for efficient lead discovery solutions.

• Based on end use, pharmaceutical and biotechnology companies accounted for the largest revenue share of 42.77% in 2024, primarily due to their extensive investment in drug discovery programs.

• North America is dominant in the market for DNA-encoded libraries, primarily due to its biotechnology sectors and robust pharmaceutical industry.

DNA-encoded Library Market Segmentation

GranView Researchch has segmented the global DNA-encoded library market based on product & service, therapeutic area, application, end use, and region:

DNA-encoded Library Product & Service Outlook (Revenue, USD Billion, 2018 - 2030)

• Products

  • Kits & Reagents

  • Encoded Libraries

  • Others

• Services

  • Design & Synthesis Services

  • Screening Services

  • Others

DNA-encoded Library Therapeutic Area Outlook (Revenue, USD Billion, 2018 - 2030)

• Oncology

• Infectious Diseases

• Cardiovascular Diseases

• Neurological Diseases

• Autoimmune Diseases

• Metabolic Diseases

• Others

DNA-encoded Library Application Outlook (Revenue, USD Billion, 2018 - 2030)

• Hit Generation / Identification

• Hit to Lead

• Hit Validation / Optimization

• Others

DNA-encoded Library End Use Outlook (Revenue, USD Billion, 2018 - 2030)

• Academic & Research Institutes

• Pharmaceutical & Biotechnology Companies

• Contract Research Organizations

• Others

DNA-encoded Library Regional Outlook (Revenue, USD Billion, 2018 - 2030)

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • Germany

  • UK

  • France

  • Italy

  • Spain

  • Sweden

  • Denmark

  • Norway

• Asia Pacific

  • China

  • Japan

  • India

  • South Korea

  • Australia

  • Thailand

• Latin America

  • Brazil

  • Argentina

• Middle East and Africa (MEA)

  • South Africa

  • UAE

  • Saudi Arabia

  • Kuwait

List of Key Players in the DNA-encoded Library Market

• Merck KGaA

• GenScript

• Pharmaron

• WuXi Biology

• Aurigene Pharmaceutical Services

• BOC Sciences

• LGC Bioresearch Technologies

• SPT Labtech Ltd

• Life Chemicals

• Charles River Laboratories